Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2019 Aug;69(2):206–211. doi: 10.1097/MPG.0000000000002405

Figure 1. Progression from ARP to CP in the INSPPIRE cohort.

Figure 1.

(A) Kaplan-Meier curve (with 95% CI, dashed lines) for the outcome of progression to CP, with estimate of median time to progression of 3.79 (IQR: 1.11–8.46) years. (B) Comparison of Kaplan-Meier of CP progression between those with and without PRSS1 variant showing a significantly faster rate of progression to CP among those with PRSS1 variant with hazard ratio of progression of 1.68; 95% CI 1.22, 2.32; p=0.001). Median time of progression to CP was 2.52 [0.25–5.50] years vs 4.48 [1.25–8.87] years, respectively.